338 related articles for article (PubMed ID: 16890302)
21. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
[TBL] [Abstract][Full Text] [Related]
22. Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors.
Micale N; Ettari R; Schirmeister T; Evers A; Gelhaus C; Leippe M; Zappalà M; Grasso S
Bioorg Med Chem; 2009 Sep; 17(18):6505-11. PubMed ID: 19709887
[TBL] [Abstract][Full Text] [Related]
23. The impact of whole genome sequence data on drug discovery--a malaria case study.
Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
[TBL] [Abstract][Full Text] [Related]
24. The Ionic and hydrophobic interactions are required for the auto activation of cysteine proteases of Plasmodium falciparum.
Sundararaj S; Singh D; Saxena AK; Vashisht K; Sijwali PS; Dixit R; Pandey KC
PLoS One; 2012; 7(10):e47227. PubMed ID: 23077573
[TBL] [Abstract][Full Text] [Related]
25. Labelling of four distinct trophozoite falcipains of Plasmodium falciparum by a cystatin-derived probe.
Florent I; Lecaille F; Montagne JJ; Gauthier F; Schrével J; Lalmanach G
Biol Chem; 2005 Apr; 386(4):401-6. PubMed ID: 15899703
[TBL] [Abstract][Full Text] [Related]
26. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum.
Shenai BR; Sijwali PS; Singh A; Rosenthal PJ
J Biol Chem; 2000 Sep; 275(37):29000-10. PubMed ID: 10887194
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
[TBL] [Abstract][Full Text] [Related]
28. Centenary celebrations article: Cysteine proteases of human malaria parasites.
Pandey KC
J Parasit Dis; 2011 Oct; 35(2):94-103. PubMed ID: 23024488
[TBL] [Abstract][Full Text] [Related]
29. Falcipain inhibition as a promising antimalarial target.
Marco M; Coterón JM
Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
[TBL] [Abstract][Full Text] [Related]
30. Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum.
Malhotra P; Dasaradhi PV; Kumar A; Mohmmed A; Agrawal N; Bhatnagar RK; Chauhan VS
Mol Microbiol; 2002 Sep; 45(5):1245-54. PubMed ID: 12207693
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d.
Eksi S; Czesny B; van Gemert GJ; Sauerwein RW; Eling W; Williamson KC
Antimicrob Agents Chemother; 2007 Mar; 51(3):1064-70. PubMed ID: 17178799
[TBL] [Abstract][Full Text] [Related]
32. Allosteric regulation of the Plasmodium falciparum cysteine protease falcipain-2 by heme.
Marques AF; Gomes PS; Oliveira PL; Rosenthal PJ; Pascutti PG; Lima LM
Arch Biochem Biophys; 2015 May; 573():92-9. PubMed ID: 25791019
[TBL] [Abstract][Full Text] [Related]
33. Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport.
Singh A; Rosenthal PJ
J Biol Chem; 2004 Aug; 279(34):35236-41. PubMed ID: 15192087
[TBL] [Abstract][Full Text] [Related]
34. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
Naughton JA; Nasizadeh S; Bell A
Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
[TBL] [Abstract][Full Text] [Related]
35. Falcipain cysteine proteases require bipartite motifs for trafficking to the Plasmodium falciparum food vacuole.
Subramanian S; Sijwali PS; Rosenthal PJ
J Biol Chem; 2007 Aug; 282(34):24961-9. PubMed ID: 17565983
[TBL] [Abstract][Full Text] [Related]
36. Stage-specific antimalarial activity of cysteine protease inhibitors.
Shenai BR; Semenov AV; Rosenthal PJ
Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
[TBL] [Abstract][Full Text] [Related]
37. Blocking Plasmodium falciparum development via dual inhibition of hemoglobin degradation and the ubiquitin proteasome system by MG132.
Prasad R; Atul ; Kolla VK; Legac J; Singhal N; Navale R; Rosenthal PJ; Sijwali PS
PLoS One; 2013; 8(9):e73530. PubMed ID: 24023882
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease.
Venturini G; Colasanti M; Salvati L; Gradoni L; Ascenzi P
Biochem Biophys Res Commun; 2000 Jan; 267(1):190-3. PubMed ID: 10623597
[TBL] [Abstract][Full Text] [Related]
39. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
Singh A; Rosenthal PJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
[TBL] [Abstract][Full Text] [Related]
40. Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax.
Na BK; Shenai BR; Sijwali PS; Choe Y; Pandey KC; Singh A; Craik CS; Rosenthal PJ
Biochem J; 2004 Mar; 378(Pt 2):529-38. PubMed ID: 14629194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
